Sam L. Barker, Director at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 24,000 shares at $1.17 ($28K) on 2019-08-02, disclosed to the SEC on 2019-08-02.
Open-market purchase of $28k LXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 12,000 | $14K | 49.8% |
| 2 | $1.18 | 12,000 | $14K | 50.2% |
| Total | $1.18 avg | 24,000 | $28K | 100% |
| Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |
| CADX | BUY | 2011-05-11 | $63K | — | Filing → |